Donna Mazloomdoost, MD
Urogynecology and Reconstructive Pelvic Surgery · Annandale, VANPI 1871704171
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Medtronic at 24.6% of the total. Reporting peaked in 2021 at $448 and has fallen 85.9% since, to $63 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in VA, where the typical reported total is $3,461.
Across 22 payments — averaging $60.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$326
- Caldera Medical, Inc$231
- Axonics, Inc.$208
- Coloplast$161
- Heron Therapeutics, Inc.$121
- AbbVie$100
- plus $180 from 3 others
What the payments were for
- Food & beverage$1,25895%
- Gifts$695%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 3 | $326 |
| Caldera Medical, Inc | 3 | $231 |
| Axonics, Inc. | 5 | $208 |
| Coloplast | 2 | $161 |
| Heron Therapeutics, Inc. | 1 | $121 |
| AbbVie(2 entities) | 5 | $100 |
| Renovia Inc | 1 | $75 |
| Boston Scientific | 1 | $63 |
| Rochester Medical Corporation | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,328 in reported general payments places this provider in the 30th percentile of 29 urogynecology and reconstructive pelvic surgery providers in Virginia.
See all urogynecology and reconstructive pelvic surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 220 | $135,119 |
| GemtesaVibegron | 91 | $85,252 |
| Estradiol | 89 | $8,730 |
| EstringEstradiol | 13 | $7,007 |
| Methenamine Hippurate | 14 | $798 |
| Trospium Chloride | 13 | $487 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $184 |
| Nortriptyline Hcl | 14 | $116 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Annandale
- Jeffrey WelgossAnnandale$50K
- Walter von PechmannAnnandale$6K
- Nicolette HorbachAnnandale$661
- Seyed ShobeiriFalls Church$116K
- Kurt McCammonVirginia Beach$67K
- Nathan GueretteMidlothian$20K
- Eric ChangStafford$11K
- Patricia MwesigwaArlington$8K
- Anna TrikhachevaPortsmouth$6K
- Mary BurnsViriginia Beach$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.